Literature DB >> 26150257

The concept and evolution of involved site radiation therapy for lymphoma.

Lena Specht1, Joachim Yahalom2.   

Abstract

We describe the development of radiation therapy for lymphoma from extended field radiotherapy of the past to modern conformal treatment with involved site radiation therapy based on advanced imaging, three-dimensional treatment planning and advanced treatment delivery techniques. Today, radiation therapy is part of the multimodality treatment of lymphoma, and the irradiated tissue volume is much smaller than before, leading to highly significant reductions in the risks of long-term complications.

Entities:  

Keywords:  Lymphoma; Radiation therapy

Mesh：

Year:  2015        PMID： 26150257     DOI： 10.1007/s10147-015-0863-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  77 in total

1.  A study of Hodgkin's disease treated by irradiation.

Authors:  M V PETERS; K C MIDDLEMISS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1958-01

2.  Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.

Authors:  Anthony J Swerdlow; Rosie Cooke; Andrew Bates; David Cunningham; Stephen J Falk; Dianne Gilson; Barry W Hancock; Sarah J Harris; Alan Horwich; Peter J Hoskin; David C Linch; T Andrew Lister; Helen H Lucraft; John A Radford; Andrea M Stevens; Isabel Syndikus; Michael V Williams
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

3.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Authors:  Lois B Travis; Deirdre Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Eero Pukkala; Charles F Lynch; David Pee; Susan A Smith; Mars B Van't Veer; Timo Joensuu; Hans Storm; Marilyn Stovall; John D Boice; Ethel Gilbert; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

4.  Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment position.

Authors:  Bart Reymen; Sylvie Spiessens; Yolande Lievens
Journal:  Radiother Oncol       Date:  2010-02-12       Impact factor: 6.280

5.  Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.

Authors:  Maja V Maraldo; Bouthaina S Dabaja; Andrea R Filippi; Tim Illidge; Richard Tsang; Umberto Ricardi; Peter M Petersen; Deborah A Schut; John Garcia; Jayne Headley; Amy Parent; Benoit Guibord; Riccardo Ragona; Lena Specht
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-07       Impact factor: 7.038

6.  The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.

Authors:  Anni Y S Jørgensen; Maja V Maraldo; Nils Patrik Brodin; Marianne C Aznar; Ivan R Vogelius; Per Munck Af Rosenschöld; Peter M Petersen; Lena Specht
Journal:  Acta Oncol       Date:  2013-10       Impact factor: 4.089

7.  Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma.

Authors:  Maja V Maraldo; Marianne C Aznar; Ivan R Vogelius; Peter M Petersen; Lena Specht
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-29       Impact factor: 7.038

8.  Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.

Authors:  Marie L De Bruin; Lucille D A Dorresteijn; Mars B van't Veer; Augustinus D G Krol; Helena J van der Pal; Arnoud C Kappelle; Willem Boogerd; Berthe M P Aleman; Flora E van Leeuwen
Journal:  J Natl Cancer Inst       Date:  2009-06-17       Impact factor: 13.506

9.  Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.

Authors:  Yuanlin Xu; Huaqing Wang; Shiyong Zhou; Man Yu; Xianhuo Wang; Kai Fu; Zhengzi Qian; Huilai Zhang; Lihua Qiu; Xianming Liu; Ping Wang
Journal:  Leuk Lymphoma       Date:  2012-11-26

Review 10.  The place of radiation therapy in the treatment of non-Hodgkin's lymphomas.

Authors:  S Hellman; J T Chaffey; D S Rosenthal; W C Moloney; G P Canellos; A T Skarin
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860
View more
  7 in total

1.  ISRT: a new radiation therapy for malignant lymphomas: Introduction to the review article by Specht and Yahalom.

Authors:  Keisuke Sasai; Masahiko Oguchi
Journal:  Int J Clin Oncol       Date:  2015-07-11       Impact factor: 3.402

Review 2.  Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.

Authors:  Andrea Riccardo Filippi; Mario Levis; Rahul Parikh; Bradford Hoppe
Journal:  Curr Oncol Rep       Date:  2017-05       Impact factor: 5.075

3.  Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.

Authors:  Anita Kumar; Carla Casulo; Joachim Yahalom; Heiko Schöder; Paul M Barr; Philip Caron; April Chiu; Louis S Constine; Pamela Drullinsky; Jonathan W Friedberg; John F Gerecitano; Audrey Hamilton; Paul A Hamlin; Steven M Horwitz; Alexandra G Jacob; Matthew J Matasar; Gianna N McArthur; Susan J McCall; Alison J Moskowitz; Ariela Noy; Maria L Palomba; Carol S Portlock; David J Straus; Nicholas VanderEls; Stephanie L Verwys; Joanna Yang; Anas Younes; Andrew D Zelenetz; Zhigang Zhang; Craig H Moskowitz
Journal:  Blood       Date:  2016-07-25       Impact factor: 22.113

4.  Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis.

Authors:  Martin D Berger; Sven Trelle; Annina E Büchi; Sabrina Jegerlehner; Codruta Ionescu; Thierry Lamy de la Chapelle; Urban Novak
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

5.  Extensive pelvic and abdominal lymphadenopathy with hepatosplenomegaly treated with radiotherapy-A case report.

Authors:  Sahil Mittal; Shaikh A Hussain; Rahul V C Tiwari; Ajith B Poovathingal; B Padma Priya; Rishabh Bhanot; Heena Tiwari
Journal:  J Family Med Prim Care       Date:  2020-02-28

6.  Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.

Authors:  Chelsea C Pinnix; Therese Y Andraos; Bouthaina Dabaja; Sarah Milgrom; Grace Smith; Dai Chihara; Andrea Ng; Luis E Fayad; Yasuhiro Oki; Sattva Neelapu; Jason Westin; M Alma Rodriguez; Loretta J Nastoupil
Journal:  Adv Radiat Oncol       Date:  2017-04-22

7.  Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

Authors:  Brandon S Imber; Karen W Chau; Jasme Lee; Jisun Lee; Dana L Casey; Joanna C Yang; N Ari Wijentunga; Annemarie Shepherd; Carla Hajj; Shunan Qi; Monica R Chelius; Paul A Hamlin; M Lia Palomba; Erel Joffe; Zhigang Zhang; Andrew D Zelenetz; Gilles A Salles; Joachim Yahalom
Journal:  Blood Adv       Date:  2021-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.